Nature's Sunshine Products, Inc. (NATR) Financial Statements (2023 and Earlier)

Company Profile

Business Address 2901 WEST BLUEGRASS BLVD.
LEHI, UT 84043
State of Incorp. UT
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments86,184 53,62950,63842,91034,060
Cash and cash equivalents86,184 53,62950,63842,91032,284
Short-term investments     1,776
Restricted cash and investments    1,9801,391
Receivables8,871 7,3197,7518,8887,738
Inventory, net of allowances, customer advances and progress billings60,852 46,66642,04844,04747,597
Inventory60,852 46,66642,04844,04747,597
Assets held-for-sale, not part of disposal group    998521
Other undisclosed current assets8,760 5,0916,3883,6868,814
Total current assets:164,667 112,705106,825102,509100,121
Noncurrent Assets
Operating lease, right-of-use asset18,349 23,951
Property, plant and equipment50,857 59,51264,06169,10673,272
Intangible assets, net (including goodwill)  567618709976
Intangible assets, net (excluding goodwill)  567618709976
Deferred costs   1,3002,0001,400
Deferred income tax assets13,590 4,899
Other noncurrent assets10,447 10,28411,14812,60813,840
Other undisclosed noncurrent assets964 1,1509,0648,26315,961
Total noncurrent assets:94,207 100,36386,19192,686105,449
TOTAL ASSETS:258,874 213,068193,016195,195205,570
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities43,949 31,32943,39831,02933,180
Accounts payable9,702 4,4065,2194,2155,305
Accrued liabilities31,600 25,53134,80124,98024,400
Taxes payable2,647 1,3923,3781,8343,475
Deferred revenue3,694 1,266
Debt1,244 4,941  9,919
Due to related parties302 1,5181,530506 
Deferred revenue and credits3,3483,672
Deferred tax liabilities  1
Contract with customer, liability1,197
Other undisclosed current liabilities27,481 18,89320,56218,77416,263
Total current liabilities:76,670 57,94766,68753,65763,035
Noncurrent Liabilities
Long-term debt and lease obligation17,093 20,213 13,181 
Long-term debt, excluding current maturities1,174   13,181 
Operating lease, liability15,919 20,213
Liabilities, other than long-term debt3,707 3,9732,0133,9923,390
Deferred compensation liability, classified964 1,1501,3081,9801,391
Deferred tax liabilities, net 7708
Deferred income tax liabilities1,566 1,655
Other liabilities1,177 1,1687051,2421,991
Other undisclosed noncurrent liabilities  1,4993,7484,6336,747
Total noncurrent liabilities:20,800 25,6855,76121,80610,137
Total liabilities:97,470 83,63272,44875,46373,172
Stockholders' equity
Stockholders' equity attributable to parent158,202 129,209120,505119,321131,112
Common stock133,382 135,741133,684131,525129,654
Accumulated other comprehensive loss(10,205) (11,225)(11,107)(10,132)(11,260)
Retained earnings (accumulated deficit)35,025 4,693(2,072)(2,072)12,718
Stockholders' equity attributable to noncontrolling interest3,202 227634111,286
Total stockholders' equity:161,404 129,436120,568119,732132,398
TOTAL LIABILITIES AND EQUITY:258,874 213,068193,016195,195205,570

Income Statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues444,084 362,215364,810342,029341,159
Revenue, net342,029341,159
Cost of revenue
(Cost of Goods and Services Sold)
(115,467) (93,940)(95,691)(91,037)(90,937)
Gross profit:328,617 268,275269,119250,992250,222
Operating expenses(154,103) (128,740)(138,431)(129,635)(120,273)
Other undisclosed operating loss(139,844) (123,410)(125,337)(119,970)(119,910)
Operating income:34,670 16,1255,3511,38710,039
Nonoperating income (expense)(2,848) (259)(2,238)1,835(773)
Investment income, nonoperating  224(87)  
Other nonoperating income (expense)(2,848) (483)(2,151)1,835(773)
Interest and debt expense(250) (43)(387)(289)(16)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes  (181)47428916
Income from continuing operations before equity method investments, income taxes:31,572 15,6423,2003,2229,266
Other undisclosed income from continuing operations before income taxes250     
Income from continuing operations before income taxes:31,822 15,6423,2003,2229,266
Income tax expense(1,615) (8,713)(4,402)(17,039)(8,591)
Net income (loss):30,207 6,929(1,202)(13,817)675
Net income (loss) attributable to noncontrolling interest(1,354) (164)3488751,464
Net income (loss) available to common stockholders, diluted:28,853 6,765(854)(12,942)2,139

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net income (loss):30,207 6,929(1,202)(13,817)675
Comprehensive income (loss):30,207 6,929(1,202)(13,817)675
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(1,354) (164)3488751,464
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1,104 46(1,323)253(1,481)
Comprehensive income (loss), net of tax, attributable to parent:29,957 6,811(2,177)(12,689)658

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: